Respirerx Pharmaceuticals Stock Price To Earning
| RSPIDelisted Stock | USD 0.01 0.00 0.00% |
RespireRx Pharmaceuticals fundamentals help investors to digest information that contributes to RespireRx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of RespireRx Pink Sheet. The fundamental analysis module provides a way to measure RespireRx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RespireRx Pharmaceuticals pink sheet.
RespireRx |
RespireRx Pharmaceuticals Company Price To Earning Analysis
RespireRx Pharmaceuticals' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current RespireRx Pharmaceuticals Price To Earning | (0.25) X |
Most of RespireRx Pharmaceuticals' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RespireRx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, RespireRx Pharmaceuticals has a Price To Earning of -0.25 times. This is 100.97% lower than that of the Pharmaceuticals sector and 105.07% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.87% higher than that of the company.
RespireRx Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RespireRx Pharmaceuticals' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RespireRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing RespireRx Pharmaceuticals by comparing valuation metrics of similar companies.RespireRx Pharmaceuticals is currently under evaluation in price to earning category among its peers.
RespireRx Fundamentals
| Return On Asset | -8.34 | ||||
| Current Valuation | 3.18 M | ||||
| Shares Outstanding | 119.59 M | ||||
| Shares Owned By Insiders | 20.63 % | ||||
| Number Of Shares Shorted | 126 | ||||
| Price To Earning | (0.25) X | ||||
| Price To Sales | 1,051 X | ||||
| EBITDA | (2.42 M) | ||||
| Net Income | (3.14 M) | ||||
| Cash And Equivalents | 21 | ||||
| Total Debt | 2.42 M | ||||
| Current Ratio | 0.01 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (956.17 K) | ||||
| Short Ratio | 1.47 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.3 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 837.16 K | ||||
| Total Asset | 208.74 K | ||||
| Retained Earnings | (156.09 M) | ||||
| Working Capital | (4.89 M) | ||||
| Current Asset | 157 K | ||||
| Current Liabilities | 5.05 M | ||||
| Net Asset | 208.74 K |
About RespireRx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RespireRx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RespireRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RespireRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in RespireRx Pink Sheet
If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |